Big Pharma Has $1.3 Trillion to Spend. The Clock Is Running.
Monetary Elite A patent cliff with a known deadline is forcing the largest acquisition wave in biopharma history.
A patent cliff with a known deadline is forcing the largest acquisition wave in biopharma history.